http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c20c5d8d8ba117ffc8a74d166725b733
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Azambuja de Azambuja |
| name | Evandro de Azambuja |
| given-name | Evandro de Evandro |
| organization-name | Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: evandro.azambuja@bordet.be. BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Belgium (Belgium) Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium Institut Jules Bordet Université Libre de Bruxelles (U.L.B) Brussels Belgium Dimitrios Zardavas, Breast International Group; Martine J. Piccart-Gebhart and Evandro de Azambuja, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Thomas M. Suter, Bern University Hospital, Bern; Jutta Steinseifer, Johannes Noe, Sabine Lauer, and Nedal Al-Sakaff, F. Hoffmann-La Roche, Basel, Switzerland; and Dirk J. Van Veldhuisen, University Medical Center Groningen, University of Groningen, The Netherlands. Clinical Trials Support Unit, Institut Jules Bordet, and l’Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Oncology Department, Institut Jules Bordet, Brussels, Belgium Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health... 4Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium. Breast European Adjuvant Study Team, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Institut Jules Bordet and l'Université Libre de Bruxelles (ULB) Brussels Belgium From the Institut Jules Bordet; Machine Learning Group, Université Libre de Bruxelles; Hôpitaux Iris Sud–Site Etterbeek-Ixelles; Hopital Saint-Pierre, Brussels; Clinique Saint-Pierre, Ottignies; Clinique Ste Elisabeth, Namur; International Drug Development Institute, Louvain-La-Neuve, Belgium; Hospital of Prato, Prato, Italy; Institut Gustave Roussy, Villejuif, France; Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg; and University of Texas MD Anderson Cancer Center, Houston, TX. Institut Jules Bordet, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, Bruxelles, Belgium Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. From Frontier Science Scotland, Kincraig, Kingussie; Imperial College London, London; and St James's Institute of Oncology, St James Hospital, Leeds; and Heathwood and Wexham Park NHS Hospitals Foundation Trust and Mount Vernon Cancer Centre, Northwood, UK; Swiss Cardiovascular Center, University Hospital Bern; Institute of Oncology of Southern Switzerland, Bellinzona; and F. Hoffmann-La Roche, Basel, Switzerland; Institut Jules Bordet, Université Libre de Bruxelles; CHC-Clinique Saint-Joseph, Liege; and... Institut Jules Bordet et l'Université Libre de Bruxelles (ULB), Service de Médecine, boulevard de Waterloo 125, B-1000 Bruxelles. Department of Medical Oncology, Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: evandro.azambuja@bordet.be. b Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. Ciara C. O'Sullivan and Jo Anne Zujewski, National Cancer Institute, Bethesda, MD; Ian Bradbury, Christine Campbell, and Eileen Holmes, Frontier Science, Inverness-shire, Scotland; Marc Spielmann and Suzette Delaloge, Institut de Cancérologie Gustave Roussy, Villejuif, France; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland; Joseph P. Costantino and Priya Rastogi, University of Pittsburgh, Pittsburgh, PA; Dimitrios... Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY; James G. Greger Jr, GlaxoSmithKline, Collegeville, PA; Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles; Phuong Dinh, Breast International Group, Brussels; Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium; Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland; Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research,... BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium b Université Libre de Bruxelles, Brussels, Belgium;; c Breast European Adjuvant Study Team (BrEAST) Data Centre, Brussels, Belgium;; d Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium; Institut Jules Bordet – Université Libre de Bruxelles (ULB); Medical Oncology Department, Academic Promoting Team at Boulevard de Waterloo, 121, 1000, Brussels, Belgium dInstitut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium Department of Medical Oncology Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B) Brussels Belgium Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, MA; Otto Metzger-Filho, Evandro de Azambuja, Kamal S. Saini, Christos Sotiriou, and Martine Piccart-Gebhart, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium; Marion Procter, Frontier Science Scotland, Kincraig; Mitchell Dowsett and Ian Smith, Royal Marsden Hospital; Ian Smith, Institute of Cancer Research, London; David Cameron, University of... Hatem A. Azim Jr, Marianne Paesmans, Lieveke Ameye, Evandro de Azambuja, and Martine J. Piccart, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Niels Kroman and Maj-Britt Jensen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Shari Gelber, International Breast Cancer Study Group Statistical Centre, Dana-Farber Cancer Institute, Boston, MA; Nicole Rotmensz, Aron Goldhirsch, and Fedro A. Peccatori, European Institute of Oncology, Milan; Barbara... Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium Medical Oncology Clinic, Institut Jules Bordet, Brussels, Belgium Department of Medicine 1Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. Hospital de Clínicas de Porto Alegre Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. a Medical Oncology Clinic, Institut Jules Bordet, Brussels, Belgium; b Université Libre de Bruxelles, Brussels, Belgium Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium for the BRCA BCY Collaboration From the Institut Jules Bordet and Université Libre de Bruxelles, Brussels; Hopital de Jolimont-Lobbes; Centre Hospitalier Universitaire de Tivoli, La Louvière; Clinique Sainte Elisabeth, Namur; Hôpital de Braine L'Alleud, Waterloo; Centre Hospitalier Universitaire de Liège; Centre Hospitalier Chrétien, Liège; Service d'Oncologie, Cliniques Universitaires Université Catholique de Louvain, Godinne; Clinique Saint-Joseph, Arlon; Réseau Hospitalier de Médecine Sociale, Tournai, Belgium; Programa de Pós... Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom; Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy; Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles; Debora Fumagalli, Breast International Group, Brussels, Belgium; Severine Sarp, Novartis Pharma AG, Basel, Switzerland; Antonio C. Wolff, Johns Hopkins School of... Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology; Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain; Holger Eidtmann, University Hospital Kiel, Kiel; Nadia Harbeck, University of Munich, Munich, Germany; Eileen Holmes, Frontier Science Scotland, Kincraig, United... 5Institut Jules Bordet and L’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Sherene Loi, Nicolas Sirtaine, Roberto Salgado, Françoise Van Eenoo, Ghizlane Rouas, Stefan Michiels, Martine J. Piccart, and Christos Sotiriou, Institut Jules Bordet, Brussels; Fanny Piette and Emmanuel Quinaux, International Drug Development Institute, Louvain-la-Neuve, Belgium; Giuseppe Viale, University of Milan, Milan; Angelo Di Leo, Hospital of Prato, Prato, Italy; Prudence Francis, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australian and New Zealand Breast Cancer Trials Group, Newcastle,... Medical Oncology Department, Institut Jules Bordet, Br.E.A.S.T. Data Centre Brussels, Blvd de Waterloo, 121 (7th Floor), 1000 Brussels, Belgium Institut Jules Bordet and L’Université Libre de Bruxelles, Brussels, Belgium Department of Medicine Institut Jules Bordet and Université Libre de Bruxelles (ULB) Brussels Belgium Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium; Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium; Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ; Giuseppe Viale,... Breast Office Medical Director, Jules Bordet Institute, 125, Bd. de Waterloo, 1000 Brussels, Belgium From the Department of Academic Biochemistry, Royal Marsden Hospital, London, United Kingdom; Frontier Science (Scotland) Ltd, Kincraig, Kingussie, Scotland; National Cancer Institute, National Institutes of Health, Bethesda, MD; Departments of Medical Oncology and Medicine, Institut Jules Bordet, Université Libre de Bruxelles; Breast European Adjuvant Studies Team, Brussels, Belgium; Department of Public Health, School of Nursing, University of Athens, Athens, Greece; TARGOS Molecular Pathology GmbH,... Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Otto Metzger-Filho, Evandro de Azambuja, Kamal S. Saini, Sherene Loi, Hatem A. Azim Jr, Christos Sotiriou, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Andrew Tutt and Paul Ellis, King's College London, Guy's Campus, London; Judith M. Bliss, Institute of Cancer Research, Sutton; Ian Bradbury, Frontier Science, Kincraig, Scotland, United Kingdom; Giuseppe Viale, European Institute of Oncology, University of Milan, Milan; Angelo Di Leo, Hospital of... Authors' Affiliation: Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Medical Department, Institut Jules Bordet and L’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium BrEAST Data Centre, Institut Jules Bordet, l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium 12Jules Bordet Institute, Brussels, Belgium. Jules Bordet Institute Brussels Belgium Academic Trials Promoting Team Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B) Brussels Belgium Institut Jules Bordet, Brussels, Belgium; l’Université Libre de Bruxelles, Brussels, Belgium |
Incoming Links
Total number of triples: 266.